BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19527301)

  • 21. Effect of weight loss on free insulin-like growth factor-I in obese women with hyposomatotropism.
    Rasmussen MH; Juul A; Hilsted J
    Obesity (Silver Spring); 2007 Apr; 15(4):879-86. PubMed ID: 17426323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid suppressing action of insulin-like growth factor-I (IGF-I) on GH release from anterior pituitary cells of goats.
    Katoh K; Shimoguchi R; Ishiwata H; Obara Y
    Domest Anim Endocrinol; 2004 Apr; 26(3):177-88. PubMed ID: 15036373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacokinetics, pharmacodynamics, safety and tolerability following 7 days daily oral treatment with NN703 in healthy male subjects.
    Zdravkovic M; Christiansen T; Eliot L; Agersoe H; Thomsen MS; Falch JF; Søgaard B; Ynddal L; Ilondo MM
    Growth Horm IGF Res; 2001 Feb; 11(1):41-8. PubMed ID: 11437473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone and insulin-like growth factor binding protein-1 responses to oral glucose in patients with primary hyperparathyroidism.
    Díez JJ; Grande C; Méndez J; González-Gancedo P; Iglesias P
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):27-34. PubMed ID: 16817815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR; Stuckey BG; Norman RJ; Papalia MA; Drillich A; Bell RJ
    Menopause; 2008; 15(6):1065-9. PubMed ID: 18806686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Oral administration effects, with different doses, of arginine aspartate and arginine chlorhydrate upon growth hormone and free fatty acids plasmatic rates in normal fasting children (author's transl)].
    Elsair J; Poey J; Rochiccioli P; Denine R; Merad R; Benouniche N
    Pathol Biol (Paris); 1980 Dec; 28(10):639-44. PubMed ID: 7007997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth hormone and ghrelin secretion in severely obese women before and after bariatric surgery.
    Valera Mora ME; Manco M; Capristo E; Guidone C; Iaconelli A; Gniuli D; Rosa G; Calvani M; Mingrone G
    Obesity (Silver Spring); 2007 Aug; 15(8):2012-8. PubMed ID: 17712119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
    Akin F; Yaylali GF; Turgut S; Kaptanoglu B
    Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral arginine-lysine does not increase growth hormone or insulin-like growth factor-I in old men.
    Corpas E; Blackman MR; Roberson R; Scholfield D; Harman SM
    J Gerontol; 1993 Jul; 48(4):M128-33. PubMed ID: 8315224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone secretion is impaired in amyotrophic lateral sclerosis.
    Morselli LL; Bongioanni P; Genovesi M; Licitra R; Rossi B; Murri L; Rossi G; Martino E; Gasperi M
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):385-8. PubMed ID: 16918961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen effects on plasma GH, IGF-I, and 41-kDa IGFBP in coho salmon (Oncorhynchus kisutch).
    Larsen DA; Shimizu M; Cooper KA; Swanson P; Dickhoff WW
    Gen Comp Endocrinol; 2004 Oct; 139(1):29-37. PubMed ID: 15474533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cranially irradiated adult cancer survivors may have normal spontaneous GH secretion in the presence of discordant peak GH responses to stimulation tests (compensated GH deficiency).
    Darzy KH; Thorner MO; Shalet SM
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):287-93. PubMed ID: 18673465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth hormone responses to varying doses of oral arginine.
    Collier SR; Casey DP; Kanaley JA
    Growth Horm IGF Res; 2005 Apr; 15(2):136-9. PubMed ID: 15809017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D and growth hormone regulate growth hormone/insulin-like growth factor (GH-IGF) axis gene expression in human fetal epiphyseal chondrocytes.
    Fernández-Cancio M; Audi L; Carrascosa A; Toran N; Andaluz P; Esteban C; Granada ML
    Growth Horm IGF Res; 2009 Jun; 19(3):232-7. PubMed ID: 19056306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men.
    Copinschi G; Van Onderbergen A; L'Hermite-Balériaux M; Mendel CM; Caufriez A; Leproult R; Bolognese JA; De Smet M; Thorner MO; Van Cauter E
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2776-82. PubMed ID: 8768828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in growth hormone and insulin-like growth factor-I levels in the acute stage after open heart surgery and at the time of discharge.
    Nakhjavani M; Esteghamati A; Hamidi S; Esfahanian F; Nabavi H; Abbasi M; Mirkhani SH
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):413-6. PubMed ID: 19609843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoassays for the measurement of IGF-II, IGFBP-2 and -3, and ICTP as indirect biomarkers of recombinant human growth hormone misuse in sport. Values in selected population of athletes.
    Abellan R; Ventura R; Palmi I; di Carlo S; Bacosi A; Bellver M; Olive R; Pascual JA; Pacifici R; Segura J; Zuccaro P; Pichini S
    J Pharm Biomed Anal; 2008 Nov; 48(3):844-52. PubMed ID: 18617352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporal changes in insulin-like growth factors I and II and in insulin-like growth factor binding proteins 1, 2, and 3 in human milk.
    Milsom SR; Blum WF; Gunn AJ
    Horm Res; 2008; 69(5):307-11. PubMed ID: 18259111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased GH secretion in scrapie, a prion-associated neurodegenerative disease, is not due to suppressed IGF-1 negative feedback.
    Viguié C; Picard-Hagen N; Gayrard V; Toutain PL
    Domest Anim Endocrinol; 2009 Apr; 36(3):127-37. PubMed ID: 19179038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis.
    Hamaguchi Y; Fujimoto M; Matsushita T; Hasegawa M; Takehara K; Sato S
    J Rheumatol; 2008 Dec; 35(12):2363-71. PubMed ID: 19004037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.